Ursodeoxycholic acid enhances the absorption of cyclosporine in a heart transplant patient with short bowel syndrome.
Gutzler
F
F
Department of Internal Medicine, University of Heidelberg, Germany.
Zimmermann
R
R
Ring
G H
GH
Sauer
P
P
Stiehl
A
A
D000284:Administration, Oral; D001379:Azathioprine / Q000008:administration & dosage; D016572:Cyclosporine / Q000008:administration & dosage / Q000493:pharmacokinetics*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000188:drug therapy / Q000503:physiopathology; D016027:Heart Transplantation / Q000502:physiology*; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects* / Q000502:physiology; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D008875:Middle Aged; D011183:Postoperative Complications / Q000188:drug therapy / Q000503:physiopathology; D012778:Short Bowel Syndrome / Q000503:physiopathology*; D014580:Ursodeoxycholic Acid / Q000008:administration & dosage*
D014580:Ursodeoxycholic Acid; D016572:Cyclosporine; D001379:Azathioprine; D008775:Methylprednisolone